Breakthrough: Cancer cells have a molecular 'switch' that could be rewired to behave normally

Cancer is sometimes described as the unchecked growth of abnormal cells. It is linked to all sorts of health issues, and doctors have spent years trying to find better ways to tackle it.

In a recent study, investigators reported the discovery of a molecular “switch” that seems to reverse damaged cells back into a more helpful condition.

The research was led by Kwang-Hyun Cho of the Korea Advanced Institute of Science and Technology (KAIST).

Reprograming cancer cells

Most therapies focus on destroying cancer cells or removing them. This new approach is different because it directs abnormal cells to change course.

Scientists tested the plan on lab-grown organoids made from colon tumors. They stopped the cells from going down the wrong path, which introduces the idea of an unexpected therapy option.

Why the research matters

Experts say that too many cancer treatments harm healthy cells while trying to kill the diseased ones. The damage often leads to side effects and even long-term complications.

Dr. Tiffany Troso-Sandoval is a retired oncologist, formerly at Memorial Sloan Kettering Cancer Center, who was not involved in the study.

“This finding provides a new approach for cancer treatment by rewiring cancer cells rather than eliminating them,” said Dr. Troso-Sandoval. She believes this work might someday open safer treatment alternatives for those who need them.

How normal cells can change

Everything starts with DNA, the genetic code that tells cells how to function. When changes build up in DNA, cells can start acting oddly.

At a certain point, these cells can switch from normal to malignant. This shift might be driven by carcinogens like chemicals in cigarette smoke or other harmful exposures. Once it happens, the body faces new challenges.

Short window to reverse cancer cells

The researchers found that there is a short interval when cells have both harmless and dangerous traits. During that moment, they are vulnerable to the right nudge.

The scientists observed a specific enzyme that stops certain proteins from breaking down. By interfering with that enzyme, the cells went back to operating as normal tissue.

Less toxicity, fewer worries

Chemotherapy and radiation are still mainstays in cancer care. However, they come with fatigue, hair loss, and other problems that many people dread.

If future work confirms that targeting these transitional cells is a safe strategy, patients might avoid some of the harsh downsides of cancer therapy. Lower toxicity may also mean a better quality of life.

This method could potentially slow or stop tumors before they truly get started. Some individuals with close relatives who have cancer might benefit from this discovery.

As soon as experts figure out how to track the early shifts in cells, doctors could potentially use this insight to steer risky tissues back to normal.

Signals that control cancer cell behavior

Cho’s team watched how colon cells changed in tiny 3D cultures. These samples allowed the scientists to see the subtle shift in cell identity.

The study also highlighted the genetic networks at play. The data offer a map of which molecules push cells down dangerous roads.

No one is suggesting that surgeons can ditch their operating rooms tomorrow. Additional research must confirm the safety of reversing tumor cells inside the human body.

Animal tests, and eventually clinical trials, are needed to see if this plan works in real life. In time, it could be used alongside current therapies, giving doctors more choices.

Perspectives in modern oncology

Scientists have learned a lot from advanced genetics tools. They can now see patterns in tumors that were invisible decades ago.

This has led to more refined solutions, including immunotherapies that harness the body’s own defenses. Reverting cells may add yet another tool to that kit, and each tool could serve a different need.

While the study was focused on colon tumors, the underlying process might affect other forms of the disease.

If these molecular signals apply to lung, breast, or other types of cancer cells, doctors may soon have a fresh way to respond. Labs around the world will likely explore that angle.

Switching harmful cells to a friendly state

Scientists hope that mapping the triggers in each patient’s cells will yield precise treatment options.

When doctors can find the exact pathways that shift cells toward disease, they might dial those pathways back. As a result, the body may keep cells on a healthier track.

The researchers remain cautious about announcing any cures. They know from experience that early lab work can change once tested more broadly.

Regardless, there is much hope for a method that might switch harmful cells back to a friendlier state. It taps into a puzzle that scientists have studied for years.

Going forward, gathering more data on other cell types is a top priority. Scientists want to see if the same enzyme blockade works on different tissues.

They also aim to reveal more about how these transitional cells behave in diverse environments. Understanding that might help doctors find the perfect moment to act.

The study is published in the journal Advanced Science.

—–

Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates. 

Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.

—–